Patents Represented by Attorney McDonnell Boehnen Hulbert & Bergohoff LLP
  • Patent number: 6962934
    Abstract: The present invention relates to compounds of formula (I): useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
    Type: Grant
    Filed: January 6, 2003
    Date of Patent: November 8, 2005
    Assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company
    Inventors: Martha A. Warpehoski, Barbara Jagodzinska